You are here : Network » Registry for NT » Member Details Little font Medium font Large font
Professor Nick Anstey
Prof. Nicholas Anstey
Menzies School of Health Research logo

Position

Head and Senior Principal Research Fellow,
International Health Division

Contact

Menzies School of Health Research
PO Box 41096
Casuarina NT 0810, AUSTRALIA

Email: nicholas.anstey@menzies.edu.au
www.menzies.edu.au

Research interests

malaria, infectious and tropical diseases, parasitology, sepsis, tuberculosis

Qualifications

PhD 2000 University of Western Australia
FRACP 1992 Royal Australasian College of Physicians
MSc 1989 University of London
DTM & H 1989 Royal College of Physicians
MB, BS(Hons) 1985 University of Western Australia

Five Most Significant Publications

1. Anstey NM, Weinberg JB, Hassanali MY, et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 1996; 184: 557-567. IF: 14

2. The SEAQUAMAT Trial Group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005; 366: 717-725. IF: 23.9

3. Lopansri BK, Anstey NM, Weinberg JB, Hobbs MR, Levesque MC, Mwaikambo ED, Granger DL. Low plasma arginine levels in children with cerebral malaria and decreased nitric oxide production. Lancet 2003; 361: 676-8. IF: 23.9

4. Anstey NM, Handojo T, Pain MC, Kenangalem E, Tjitra E, Price RN, Maguire GP. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and post-treatment alveolar-capillary inflammation. J Infect Dis 2007; 195: 589-96 IF: 5.0

5. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CS, Granger DL, J Brice Weinberg JB, Bert K Lopansri BK, Ric N Price RN, Stephen B Duffull SB, Celermajer DS, Anstey NM. Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 2007; 204: 2693-2704. IF 14

Currently Held Grants

2008-2012: NHMRC 490307 (Practitioner Fellowship - L2): Anstey NM. Functional Pathophysiology and treatment of malaria and other tropical infectious diseases in our region.

2004-2008: NHMRC/Wellcome Trust 283321 Collaborative Research: Anstey NM, Harijanto P, Kevau I, Price RN, Sly P, Tjitra E.Research and training to reduce morbidity and mortality from malaria in Papua (Indonesia) and Papua New Guinea.

2009-2013: NHMRC 496600 Program: Kemp DJ, Good MF, McManus D, Toth I, Anstey NM, Sriprakash KS, Doolan D, Engwerda C, Loukas A. Immunity and pathogenesis of tropical and infectious diseases: Implications for vaccines and drug development

2004-2008: Wellcome Trust (UK)/NHMRC: Anstey NM, Tjitra E. Research and training to reduce morbidity from malaria in Papua (Indonesia) and Papua New Guinea

2004-2008: NIH (USA): Anstey NM, Tjitra E, Weinberg JB. Nitric oxide and severe malaria II

2005-2009: Australian Research Council RN0460368: Smith N Anstey NM and others. Australian Research Council Network for Parasitology.